Nasal immune responses to respiratory viruses in healthy and immunocompromised people
Part of Cancer, Immune system & allergy, Infections clinical trials.
This study looks at how the nose's immune system responds to common respiratory viruses in both healthy people and those with weakened immune systems. It aims to understand how long these responses last.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 90 years old.
- You must be willing to sign a consent form.
- If you are healthy, you should not have any medical conditions or be taking immune-suppressing drugs.
- If you have a weakened immune system (from a transplant, immune-suppressing treatment, or genetic condition), you can join.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This study tests how healthy adults respond to the nasal flu vaccine. You may be able to help researchers learn more about how the body reacts to this vaccine.
This trial collects nasal cell samples from healthy people to build a research biobank. It may help future studies on respiratory health.
This study collects sent-in samples to better understand how your immune system responds during a COVID-19–like illness and after you recover. It may help researchers learn why some people get sick and others stay uninfected, and how immune protection works over time.
This study examines how the body's natural defense system (specifically a type of immune protein) responds to common respiratory viruses like flu and cold in older adults. Researchers will analyze nasal samples that are already being collected as part of routine care to better understand why older people sometimes have different immune responses to these infections.
This study looks at how well vaccines for respiratory viruses work in people with weakened immune systems. It may help doctors give better vaccine advice to patients like you.
Hear when a new Immunocompromised Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.